Abstract
Fructo-oligosaccharide (FOS) is a prebiotic that stimulates the colonic growth of bifidobacteria to promote intestinal health. This study assessed whether FOS can reduce intestinal damage associated with ulcerative colitis and accelerate recovery in a mouse model. C57BL/6 mice received 2% dextran sulphate sodium for 7 days (days 8–14). FOS (1.5 g/mL) treatment was administered twice daily (n=10/group): before and during colitis (days 1–14); during colitis (days 10–14); and during colitis and the recovery period (days 10–19). Disease activity was scored daily and colonic damage was assessed by histological analysis. FOS treatment significantly reduced disease activity and damage in the distal colon (P < .05). Treatment with FOS (days 10–14) had increased crypt depth (116±6 μm) compared to water treatment (90±4 μm, P < .05). FOS treatment (days 10–19) produced a faster recovery from damage with increased crypt depth and crypt area. These results demonstrate the protective effect of FOS treatment.
Similar content being viewed by others
References
Rutgeerts P (2002) A critical assessment of new therapies in inflammatory bowel disease. J Gastroenterol Hepatol 17:176–185
Ardizzone S, Bianchi Porro G (2002) Inflammatory bowel disease: new insights into pathogenesis and treatment. J Int Med 252:475–496
Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, Caprilli R (1999) Dextran sulfate sodium (DSS) colitis in rats. Dig Dis Sci 44:1458–1475
Carter M, Lobo A, Travis S (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53:v1–v16
Farrell R, Peppercorn M (2002) Ulcerative colitis. Lancet 359:331–340
Vowinkel T, Kalogeris T, Mori M, Krieglstein C, Granger N (2004) Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci 49:556–564
Cherbut C, Michel C, Lecannu G (2003) The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133:21–27
Videla S, Vilaseca J, Antolin M, Garcia-Lafuente A, Guarner F, Crespo E, Casalots J, Salas A, Malagelada J (2001) Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 96:1486–1493
Gibson G, Roberfroid M (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412
Mitsuoka T, Hidaka H, Eida T (1987) Effect of fructo-oligosaccharides on intestinal microflora. Die Nahrung 31:427–436
Reddy B (1999) Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumour growth. J Nutr 129:1478S–1482S
Bornet F, Brouns F (2002) Immune-stimulating and gut health-promoting properties of short-chain fructo-oligosaccharides. Nutr Rev 60:326–334
Le Blay G, Michel C, Blottiere H, Cherbut C (1999) Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in caecal butyrate in rats. J Nutr 129:2231–2235
Marteau P, Boutron-Ruault C (2002) Nutritional advantages of probiotics and prebiotics. Br J Nutr 87:S153–S157
Probert H, Gibson G (2002) Investigating the prebiotic and gas-generating effects of selected carbohydrates on the human colonic microflora. Lett Appl Microbiol 35:473–480
Ohta A, Baba S, Ohtsuki M, Taguchi A, Adachi T (1996) Prevention of coprophagy modifies magnesium absorption in rats fed with fructo-oligosaccharides. Br J Nutr 75:775–784
Tahiri M, Tressol J, Arnaud J, Bornet F, Bouteloup-Demange C, Feillet-Coudray C, Ducros V, Pepin D, Brouns F, Rayssiguier A, Coudray C (2001) Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res 16:2152–2160
Gibson G, Beatty E, Wang X, Cummings J (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108:975–982
Kaur N, Gupta A (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27:703–714
Axelsson L, Landstrom E, Bylund-Fellenius A (1998) Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther 12:925–934
Kullman F, Messmann H, Alt M, Gross V, Bocker T, Scholmerich J, Ruschoff J (2001) Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats. In J Colorectal Dis 16:238–246
Kitajima S, Takuma S, Morimoto M (1999) Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. J Vet Med Sci 61:67–70
Egger B, Bajaj-Elliott M, MacDonald T, Inglin R, Eysselein V, Buchler M (2000) Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62:240–248
Ahmad M, Krishnan S, Ramakrishna B, Mathan M, Pulimood A, Murthy S (2000) Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 46:493–499
Howarth G, Xian C, Read L (2000) Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of inflammatory bowel disease. Growth Factors 18:119–133
Murthy S, Cooper H, Shim H, Shah R, Ibrahim S, Sedergran D (1993) Treatment of dextran sulfate sodium- induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38:1722–1734
Kolida S, Tuohy K, Gibson G (2002) Prebiotic effects of inulin and oligofructose. Br J Nutr 87:S193–S197
Langlands S, Hopkins M, Coleman N, Cummings J (2004) Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53:1610–1616
Rycroft C, Jones M, Gibson G, Rastall R (2001) A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91:878–887
Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourie B, Bornet F, Rambaud J (1999) Short-Chain Fructo-oligosaccharide administration dose-dependently increases faecal bifidobacteria. J Nutr 129:113–116
Gibson G, Wang X (1994) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77:412–420
Campbell J, Fahey G, Wolf B (1997) Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal shortchain fatty acids, pH and microflora in rats. J Nutr 127:130–136
Nadeau D (2000) Intestinal warfare: the role of short-chain fructo-oligosaccharides in health and disease. Nutr Clin Care 3:266–273
Chapman M, Grahn M, Boyle M, Hutton M, Rogers J, Williams N (1994) Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 35:73–76
Tuohy K, Probert H, Smejkal C, Gibson G (2003) Using probiotics and prebiotics to improve gut health. Drug Discovery Today 8:692–700
Fujiwara M, Kaneko T, Iwana H, Taketomo N, Tsunoo H, Kanno J, Ohkusa T, Okayasu I (2003) Inhibitory effects of Bifidobacterium longum on experimental ulcerative colitis induced in mice by synthetic dextran sulfate sodium. Digestion 67:90–95
Campbell M, Kolev Y, Hendrich T, Stahl B, Boehm G, Stevenson L, Butler R (2004) The role of oligosaccharides and Helicobacter pylori-specific antibodies in prevention of gastritis. Helicobacter 9:518–525
Rumi G, Tsubouchi R, Okayama M, Kato S, Mozsik G, Takeuchi K (2004) Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig Dis Sci 49:1466–1472
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Winkler, J., Butler, R. & Symonds, E. Fructo-oligosaccharide Reduces Inflammation in a Dextran Sodium Sulphate Mouse Model of Colitis. Dig Dis Sci 52, 52–58 (2007). https://doi.org/10.1007/s10620-006-9224-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9224-z